Cargando…
The cost of illness analysis of inflammatory bowel disease
BACKGROUND: Inflammatory bowel disease (IBD) is a chronic inflammatory condition involving individuals across all age groups. Recent data suggests the increase in the prevalence of IBD and the surge in applying the biologic drugs in which both change the cost of IBD in recent years. Comprehensive as...
Autores principales: | Pakdin, Majid, Zarei, Leila, Bagheri Lankarani, Kamran, Ghahramani, Sulmaz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9854042/ https://www.ncbi.nlm.nih.gov/pubmed/36658489 http://dx.doi.org/10.1186/s12876-023-02648-z |
Ejemplares similares
-
Hospital Cost of Inflammatory Bowel Disease and Its Determinants in a Multicenter Study From Iran
por: Ghahramani, Sulmaz, et al.
Publicado: (2023) -
Inflammatory Bowel Disease during COVID-19 Pandemic: A Prospective Cohort Study of Incidence Rate and Patients’ Concerns
por: Bagheri Lankarani, Kamran, et al.
Publicado: (2022) -
Risk Factors Affecting 90-day Readmission of Patients with Inflammatory Bowel Disease
por: Ghahramani, Sulmaz, et al.
Publicado: (2022) -
Does “Overall Catastrophic Health Care Expenditure” Make Sense?
por: BAGHERI LANKARANI, Kamran, et al.
Publicado: (2018) -
Inpatient Out-of-Pocket in Iran After Health Transformation Plan
por: Ghahramani, Sulmaz, et al.
Publicado: (2018)